ID   HAOX1_RAT               Reviewed;         370 AA.
AC   B0BNF9;
DT   23-FEB-2022, integrated into UniProtKB/Swiss-Prot.
DT   26-FEB-2008, sequence version 1.
DT   27-MAR-2024, entry version 116.
DE   RecName: Full=2-Hydroxyacid oxidase 1 {ECO:0000305|PubMed:10777549};
DE            Short=HAOX1 {ECO:0000303|PubMed:10777549};
DE            EC=1.1.3.15 {ECO:0000250|UniProtKB:Q9UJM8};
DE   AltName: Full=Glycolate oxidase {ECO:0000250|UniProtKB:Q9UJM8};
DE            Short=GOX {ECO:0000250|UniProtKB:Q9UJM8};
DE   AltName: Full=Glyoxylate oxidase {ECO:0000250|UniProtKB:Q9UJM8};
DE            EC=1.2.3.5 {ECO:0000250|UniProtKB:Q9UJM8};
GN   Name=Hao1 {ECO:0000312|RGD:1589750};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10777549; DOI=10.1074/jbc.275.17.12590;
RA   Jones J.M., Morrell J.C., Gould S.J.;
RT   "Identification and characterization of HAOX1, HAOX2, and HAOX3, three
RT   human peroxisomal 2-hydroxy acid oxidases.";
RL   J. Biol. Chem. 275:12590-12597(2000).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16396499; DOI=10.1021/pr0503073;
RA   Moser K., White F.M.;
RT   "Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-
RT   MS/MS.";
RL   J. Proteome Res. 5:98-104(2006).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Broad substrate specificity (S)-2-hydroxy-acid oxidase that
CC       preferentially oxidizes glycolate. The glyoxylate produced by the
CC       oxidation of glycolate can then be utilized by alanine-glyoxylate
CC       aminotransferase for the peroxisomal synthesis of glycine; this pathway
CC       appears to be an important step for the detoxification of glyoxylate
CC       which, if allowed to accumulate, may be metabolized to oxalate with
CC       formation of kidney stones. Can also catalyze the oxidation of
CC       glyoxylate, and long chain hydroxyacids such as 2-hydroxyhexadecanoate
CC       and 2-hydroxyoctanoate. Active in vitro with the artificial electron
CC       acceptor 2,6-dichlorophenolindophenol (DCIP), but O2 is believed to be
CC       the physiological electron acceptor, leading to the production of H2O2.
CC       {ECO:0000250|UniProtKB:Q9UJM8}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a (2S)-2-hydroxycarboxylate + O2 = a 2-oxocarboxylate + H2O2;
CC         Xref=Rhea:RHEA:16789, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:35179, ChEBI:CHEBI:58123; EC=1.1.3.15;
CC         Evidence={ECO:0000250|UniProtKB:Q9UJM8};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16790;
CC         Evidence={ECO:0000250|UniProtKB:Q9UJM8};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycolate + O2 = glyoxylate + H2O2; Xref=Rhea:RHEA:25311,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:29805,
CC         ChEBI:CHEBI:36655; EC=1.1.3.15;
CC         Evidence={ECO:0000250|UniProtKB:Q9UJM8};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:25312;
CC         Evidence={ECO:0000250|UniProtKB:Q9UJM8};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glyoxylate + H2O + O2 = H(+) + H2O2 + oxalate;
CC         Xref=Rhea:RHEA:14837, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:30623,
CC         ChEBI:CHEBI:36655; EC=1.2.3.5;
CC         Evidence={ECO:0000250|UniProtKB:Q9UJM8};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14838;
CC         Evidence={ECO:0000250|UniProtKB:Q9UJM8};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-hydroxyhexadecanoate + O2 = 2-oxohexadecanoate + H2O2;
CC         Xref=Rhea:RHEA:67944, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:65097, ChEBI:CHEBI:176593;
CC         Evidence={ECO:0000250|UniProtKB:Q9UJM8};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67945;
CC         Evidence={ECO:0000250|UniProtKB:Q9UJM8};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-hydroxyoctanoate + O2 = 2-oxooctanoate + H2O2;
CC         Xref=Rhea:RHEA:67940, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:133514, ChEBI:CHEBI:176689;
CC         Evidence={ECO:0000250|UniProtKB:Q9UJM8};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67941;
CC         Evidence={ECO:0000250|UniProtKB:Q9UJM8};
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000250|UniProtKB:Q9UJM8};
CC   -!- PATHWAY: Amino-acid biosynthesis; glycine biosynthesis.
CC       {ECO:0000250|UniProtKB:Q9UJM8}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250|UniProtKB:Q9UJM8}.
CC   -!- SUBCELLULAR LOCATION: Peroxisome matrix {ECO:0000305|PubMed:10777549}.
CC   -!- SIMILARITY: Belongs to the FMN-dependent alpha-hydroxy acid
CC       dehydrogenase family. {ECO:0000255|PROSITE-ProRule:PRU00683}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR07053812; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473949; EDL80285.1; -; Genomic_DNA.
DR   EMBL; BC158804; AAI58805.1; -; mRNA.
DR   RefSeq; NP_001101250.1; NM_001107780.2.
DR   AlphaFoldDB; B0BNF9; -.
DR   SMR; B0BNF9; -.
DR   STRING; 10116.ENSRNOP00000006330; -.
DR   BindingDB; B0BNF9; -.
DR   ChEMBL; CHEMBL2021746; -.
DR   CarbonylDB; B0BNF9; -.
DR   iPTMnet; B0BNF9; -.
DR   PhosphoSitePlus; B0BNF9; -.
DR   PaxDb; 10116-ENSRNOP00000006330; -.
DR   PeptideAtlas; B0BNF9; -.
DR   Ensembl; ENSRNOT00000006330.5; ENSRNOP00000006330.3; ENSRNOG00000004601.5.
DR   GeneID; 311446; -.
DR   KEGG; rno:311446; -.
DR   AGR; RGD:1589750; -.
DR   CTD; 54363; -.
DR   RGD; 1589750; Hao1.
DR   eggNOG; KOG0538; Eukaryota.
DR   GeneTree; ENSGT00390000018717; -.
DR   HOGENOM; CLU_020639_6_1_1; -.
DR   InParanoid; B0BNF9; -.
DR   OMA; RIWFRPK; -.
DR   OrthoDB; 276514at2759; -.
DR   PhylomeDB; B0BNF9; -.
DR   TreeFam; TF313363; -.
DR   Reactome; R-RNO-389661; Glyoxylate metabolism and glycine degradation.
DR   Reactome; R-RNO-9033241; Peroxisomal protein import.
DR   UniPathway; UPA00288; -.
DR   PRO; PR:B0BNF9; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Proteomes; UP000234681; Chromosome 3.
DR   Bgee; ENSRNOG00000004601; Expressed in liver and 4 other cell types or tissues.
DR   GO; GO:0005782; C:peroxisomal matrix; ISO:RGD.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0003973; F:(S)-2-hydroxy-acid oxidase activity; ISO:RGD.
DR   GO; GO:0010181; F:FMN binding; ISO:RGD.
DR   GO; GO:0047969; F:glyoxylate oxidase activity; ISO:RGD.
DR   GO; GO:0001561; P:fatty acid alpha-oxidation; ISO:RGD.
DR   GO; GO:0006545; P:glycine biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0046296; P:glycolate catabolic process; ISO:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IEP:RGD.
DR   CDD; cd02809; alpha_hydroxyacid_oxid_FMN; 1.
DR   Gene3D; 3.20.20.70; Aldolase class I; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR012133; Alpha-hydoxy_acid_DH_FMN.
DR   InterPro; IPR000262; FMN-dep_DH.
DR   InterPro; IPR037396; FMN_HAD.
DR   InterPro; IPR008259; FMN_hydac_DH_AS.
DR   PANTHER; PTHR10578:SF137; 2-HYDROXYACID OXIDASE 1; 1.
DR   PANTHER; PTHR10578; S -2-HYDROXY-ACID OXIDASE-RELATED; 1.
DR   Pfam; PF01070; FMN_dh; 1.
DR   PIRSF; PIRSF000138; Al-hdrx_acd_dh; 1.
DR   SUPFAM; SSF51395; FMN-linked oxidoreductases; 1.
DR   PROSITE; PS00557; FMN_HYDROXY_ACID_DH_1; 1.
DR   PROSITE; PS51349; FMN_HYDROXY_ACID_DH_2; 1.
PE   1: Evidence at protein level;
KW   Amino-acid biosynthesis; Flavoprotein; FMN; Oxidoreductase; Peroxisome;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN           1..370
FT                   /note="2-Hydroxyacid oxidase 1"
FT                   /id="PRO_0000453972"
FT   DOMAIN          1..365
FT                   /note="FMN hydroxy acid dehydrogenase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00683"
FT   MOTIF           368..370
FT                   /note="Microbody targeting signal"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        260
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00683"
FT   BINDING         26
FT                   /ligand="glyoxylate"
FT                   /ligand_id="ChEBI:CHEBI:36655"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM8"
FT   BINDING         79..81
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM8"
FT   BINDING         108
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM8"
FT   BINDING         130
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM8"
FT   BINDING         132
FT                   /ligand="glyoxylate"
FT                   /ligand_id="ChEBI:CHEBI:36655"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM8"
FT   BINDING         158
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM8"
FT   BINDING         167
FT                   /ligand="glyoxylate"
FT                   /ligand_id="ChEBI:CHEBI:36655"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM8"
FT   BINDING         236
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM8"
FT   BINDING         258
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM8"
FT   BINDING         260
FT                   /ligand="glyoxylate"
FT                   /ligand_id="ChEBI:CHEBI:36655"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM8"
FT   BINDING         263
FT                   /ligand="glyoxylate"
FT                   /ligand_id="ChEBI:CHEBI:36655"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM8"
FT   BINDING         291..295
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM8"
FT   BINDING         314..315
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM8"
FT   MOD_RES         184
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WU19"
FT   MOD_RES         194
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WU19"
FT   MOD_RES         230
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM8"
SQ   SEQUENCE   370 AA;  40968 MW;  2CFD33AFCF9021B0 CRC64;
     MLPRLVCISD YEQHARTVLQ KSVYDYYKSG ANDQETLADN IRAFSRWKLY PRMLRNVADI
     DLSTSVLGQR VSMPICVGAT AMQCMAHVDG ELATVRACQT MGTGMMLSSW ATSSIEEVAE
     AGPEALRWMQ LYIYKDREVS SQLVKRAEQM GYKAIFVTVD TPYLGNRFDD VRNRFKLPPQ
     LRMKNFETND LAFSPKGNFG DNSGLAEYVA QAIDPSLSWD DIKWLRRLTS LPIVVKGILR
     GDDAQEAVKH GVDGILVSNH GARQLDGVPA TIDALPEIVE AVEGKVEVFL DGGVRKGTDV
     LKALALGARA VFVGRPIIWG LAFQGEKGVQ DVLEILKEEF RLAMALSGCQ NVKVIDKTLV
     RKNPLAVSKI
//
